Altshuler Shaham LTD Alkermes Plc. Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$28.34 - $33.63 $25,364 - $30,098	895 New	895 $28,000
Q2 2022 Aug 10, 2022	BUY	$26.4 - $30.54 $62,172 - $71,921	2,355 New	2,355 $70,000
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $49,162 - $59,646	-2,131 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$21.47 - $32.08 $41,608 - $62,171	-1,938 Reduced 47.63%	2,131 $50,000
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $53,914 - $74,123	2,307 Added 130.93%	4,069 $126,000
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $33,090 - $44,314	1,762 New	1,762 $43,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.55B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.